Clinical Trial to Investigate Safety and Efficacy of Edoxaban in Patients With CTEPH (KABUKI)

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is phase III trial to evaluate whether edoxaban, a direct factor Xa inhibitor, is noninferior to warfarin in preventing worsening of chronic thromboembolic pulmonary hypertension (CTEPH).
Epistemonikos ID: c0bf3a70dc2685a1d942bf34a4dba0c33c281a96
First added on: May 08, 2024